Real-world evidence for the effectiveness and safety of dupilumab in patients with CRSwNP after 1 year of therapy

Albrecht, Tobias; Sailer, Martin M.; Capitani, Flavia; van Schaik, Carolina; Loewenheim, Hubert; Becker, Sven

dc.contributor.author	Albrecht, Tobias
dc.contributor.author	Sailer, Martin
dc.contributor.author	Capitani, Flavia
dc.contributor.author	van Schaik, Carolina
dc.contributor.author	Löwenheim, Hubert Martin
dc.contributor.author	Becker, Sven
dc.date.accessioned	2024-01-24T15:18:05Z
dc.date.available	2024-01-24T15:18:05Z
dc.date.issued	2023
dc.identifier.issn	1939-4551
dc.identifier.uri	http://hdl.handle.net/10900/149482
dc.language.iso	en	en
dc.publisher	Amsterdam : Elsevier	de_DE
dc.relation.uri	http://dx.doi.org/10.1016/j.waojou.2023.100780
dc.subject.ddc	610	de_DE
dc.subject.ddc	570	de_DE
dc.title	Real-world evidence for the effectiveness and safety of dupilumab in patients with CRSwNP after 1 year of therapy	de_DE
dc.type	Article	de_DE
utue.quellen.id	20230928000000_01226
utue.personen.roh	Albrecht, Tobias
utue.personen.roh	Sailer, Martin M.
utue.personen.roh	Capitani, Flavia
utue.personen.roh	van Schaik, Carolina
utue.personen.roh	Loewenheim, Hubert
utue.personen.roh	Becker, Sven
dcterms.isPartOf.ZSTitelID	World Allergy Organization Journal	de_DE
dcterms.isPartOf.ZS-Issue	5	de_DE
dcterms.isPartOf.ZS-Volume	16	de_DE
utue.fakultaet	04 Medizinische Fakultät